tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
Advertisement

Inhibikase Therapeutics (IKT) Market Cap & Net Worth

Compare
171 Followers

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $118.48M as of Dec 07, 2025. Its market cap has increase by 306.67% in one year.
Market Cap
$118.48M
Enterprise Value
$87.89M
1-Year Change
306.67%
Category
Micro (Under 300M)
Stock Price
$1.5

Market Cap Chart

Market Cap History
Date
Market Cap
% Change
Dec 05, 2025
112.71M-0.66%
Dec 04, 2025
113.47M+4.86%
Dec 03, 2025
108.21M+2.13%
Dec 02, 2025
105.95M-6.00%
Dec 01, 2025
112.71M-1.32%
Nov 28, 2025
114.22M-1.30%
Nov 26, 2025
115.72M-1.91%
Nov 25, 2025
117.97M+1.29%
Nov 24, 2025
116.47M+4.03%
Nov 21, 2025
111.96M-2.61%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis